600774 Stock Overview
Hanshang Group Co., Ltd. primarily engages in the retail business.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Hanshang Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.02 |
| 52 Week High | CN¥13.77 |
| 52 Week Low | CN¥5.15 |
| Beta | 0.61 |
| 1 Month Change | 12.75% |
| 3 Month Change | 57.69% |
| 1 Year Change | -28.01% |
| 3 Year Change | -33.68% |
| 5 Year Change | -28.18% |
| Change since IPO | 128.57% |
Recent News & Updates
Shareholder Returns
| 600774 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 24.4% | 4.0% | 2.2% |
| 1Y | -28.0% | -5.0% | -10.2% |
Return vs Industry: 600774 underperformed the CN Pharmaceuticals industry which returned -6.2% over the past year.
Return vs Market: 600774 underperformed the CN Market which returned -11.3% over the past year.
Price Volatility
| 600774 volatility | |
|---|---|
| 600774 Average Weekly Movement | 9.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in CN Market | 11.0% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 600774's share price has been volatile over the past 3 months.
Volatility Over Time: 600774's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 2,105 | Fang Yang | www.whhsg.com |
Hanshang Group Co., Ltd. primarily engages in the retail business. It is also involved in medicine, medical equipment, assisted reproduction, healthy drinks, and exhibition operations. The company was incorporated in 1990 and is based in Wuhan, China.
Hanshang Group Co., Ltd. Fundamentals Summary
| 600774 fundamental statistics | |
|---|---|
| Market cap | CN¥2.61b |
| Earnings (TTM) | CN¥49.62m |
| Revenue (TTM) | CN¥1.36b |
52.5x
P/E Ratio1.9x
P/S RatioIs 600774 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600774 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.36b |
| Cost of Revenue | CN¥532.92m |
| Gross Profit | CN¥831.82m |
| Other Expenses | CN¥782.20m |
| Earnings | CN¥49.62m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.17 |
| Gross Margin | 60.95% |
| Net Profit Margin | 3.64% |
| Debt/Equity Ratio | 41.6% |
How did 600774 perform over the long term?
See historical performance and comparison